Assessing the molecules talents and therapeutic opportunities within specific disease, indications and clusters of symptoms
- Asset assessment: What can the asset do? How can we build differentiation around that?
- Pathway and Modality Mapping: Mapping the pathway and modality over the disease area pathophysiology
- Unmet Stakeholder Need Profiling: Assessing the burden of disease, needs and opportunities within current treatment paradigms
- Competitive Landscape Analysis: Analysing the current and future competitive landscape and evaluating potential opportunities
- Market Sizing and Commercial Opportunity Assessment: Modelling the market size of target disease areas and forecasting the potential commercial value
Find out how we can help. Book a 15 minute call with us here!